What is Mink Therapeutics Inc (INKT) stock price today?

Mink Therapeutics Inc (INKT) currently trades at $11.81 per share. The stock has a market capitalization of $55.32M and a P/E ratio of —x.

Is INKT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Mink Therapeutics Inc has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

INKT

Mink Therapeutics Inc

NASDAQ: INKT · HEALTHCARE · BIOTECHNOLOGY

$11.81

+8.55% today

Updated 2026-04-29

Market cap

$55.32M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.93

Dividend yield

—

52W range

$6 – $76

Volume

0.4M

Market cap

$55.32M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.93

Dividend yield

—

52W range

$6 – $76

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$39.00

+230.23%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.07M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$2.70B	$0.00	$0.00	$0.00	$0.00
Net income	$-27.99M	$-22.46M	$-10.78M	$-12.49M	$-2.60M
EPS	—	—	—	—	$-2.93
Free cash flow	$-19.12M	$-15.84M	$-9.56M	$-5.93B	$-2.07M
Profit margin	-1.03%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
INKT	$55.32M	16	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Mink Therapeutics Inc trades at $11.81. Our Smart Value Score of 16/100 indicates the stock is weak.

Frequently asked questions

What is Mink Therapeutics Inc's stock price?

Mink Therapeutics Inc (INKT) trades at $11.81.

Is Mink Therapeutics Inc overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of Mink Therapeutics Inc (INKT)?

The analyst target price is $39.00, representing +230.2% upside from the current price of $11.81.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-1,239.00%

Beta0.35

50D MA$10.99

200D MA$13.47

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

INKT vs LLY →INKT vs JNJ →INKT vs ABBV →Stock screener →